| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| CHE | Chemed Corp. | $310.14 | $4.99B | Sell |
Here's Why You Should Invest in Chemed (CHE) Stock Right Now
http://www.zacks.com/stock/news/386720/heres-why-you-should-invest-in-chemed-che-stock-right-now?cid=CS-ZC-FT-386720
Apr 18, 2019 - Chemed (CHE) is expected to benefit from the launch of its VITAS Healthcare Inpatient Hospice Unit.
0
Here's Why You Should Hold on to DaVita (DVA) Stock Now
http://www.zacks.com/stock/news/377363/heres-why-you-should-hold-on-to-davita-dva-stock-now?cid=CS-ZC-FT-377363
Apr 10, 2019 - DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, rising expenses remain a dampener.
0
These 5 Stocks Make Great Buys on New Analyst Coverage
http://www.zacks.com/stock/news/365909/these-5-stocks-make-great-buys-on-new-analyst-coverage?cid=CS-ZC-FT-365909
Mar 28, 2019 - Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
0
‘Saturday Night Live’ stars Colin Jost and Michael Che are competing in WWE Wrestlemania
http://www.nydailynews.com/entertainment/tv/ny-colin-jost-michael-che-wwe-20190326-obih7jorjfdgphjyelwi6oa5u4-story.html
Mar 26, 2019 -
It’s no joke ― “Saturday Night Live” comics Michael Che and Colin Jost will jump into the ring at Wrestlemania 35 next month.
The “Weekend Update” hosts will compete at the WWE event on April 7 against Braun Strowman, who measures in at 6-foot-8 and 385 pounds.
The comedians made the announcement...
0
Chemed (CHE) Upgraded to Strong Buy: What Does It Mean for the Stock?
http://www.zacks.com/stock/news/359807/chemed-che-upgraded-to-strong-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-359807
Mar 15, 2019 - Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
0
5 Stocks in Focus on New Analysts Coverage
http://www.zacks.com/stock/news/358623/5-stocks-in-focus-on-new-analysts-coverage?cid=CS-ZC-FT-358623
Mar 11, 2019 - Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
0
Here's Why You Should Invest in Chemed (CHE) Stock Right Now
http://www.zacks.com/stock/news/357224/heres-why-you-should-invest-in-chemed-che-stock-right-now?cid=CS-ZC-FT-357224
Feb 28, 2019 - Chemed (CHE) sees revenue growth across its wholly-owned subsidiaries, VITAS Healthcare and Roto-Rooter. Its capital deployment policy is based on buyouts and solid return of cash to shareholders.
0
Chemed (CHE) Q4 Earnings Beat Estimates, Gross Margin Falls
http://www.zacks.com/stock/news/356727/chemed-che-q4-earnings-beat-estimates-gross-margin-falls?cid=CS-ZC-FT-356727
Feb 25, 2019 - Chemed's (CHE) Q4 revenues grow across key segments.
0
Chemed Corporation (CHE) CEO Kevin McNamara on Q4 2018 Results - Earnings Call Transcript
https://seekingalpha.com/article/4243080-chemed-corporation-che-ceo-kevin-mcnamara-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare
Feb 21, 2019 - Chemed Corporation (NYSE:CHE) Q4 2018 Results Earnings Conference Call February 21, 2019, 10:00 AM ET Company Participants Sherri Warner - IR Kevin McNamara - President & CEO David Williams - EVP
0
Chemed Corp (CHE) Q4 2018 Earnings Conference Call Transcript
https://www.fool.com/earnings/call-transcripts/2019/02/21/chemed-corp-che-q4-2018-earnings-conference-call-t.aspx?source=iedfolrf0000001
Feb 21, 2019 - CHE earnings call for the period ending December 31, 2018.
0
Page 1>